Company Description
XWELL, Inc. provides health and wellness services in airport and off airport marketplaces in the United States and internationally.
It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler’s spa services, including massage, nail, and skin care services, as well as spa and travel products.
The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC’s bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.
The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services.
The Treat segment provides access to wellness services for travelers at on-site centers, consisting of self-guided yoga, meditation, and low impact weight exercises programs.
The company offers its services through stores, kiosks, and online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022.
XWELL, Inc. is based in New York, New York.
Country | United States |
Founded | 2006 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 337 |
CEO | Ezra Ernst |
Contact Details
Address: 254 West 31st Street, 11th Floor New York, New York 10001 United States | |
Phone | (212)-750-9595 |
Website | xwell.com |
Stock Details
Ticker Symbol | XWEL |
Exchange | NASDAQ |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001410428 |
CUSIP Number | 98420U802 |
ISIN Number | US98420U8027 |
SIC Code | 7200 |
Key Executives
Name | Position |
---|---|
Ezra T. Ernst | President, Chief Executive Officer and Director |
Omar A. Haynes | Vice President of Treasury and Finance |
Ian Brown | Chief Financial Officer |
Cara Soffer | Senior Vice President and General Counsel |
Mike Heronime | Marketing Director |
Peter Vermeulen | Head of Human Resources |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 13, 2025 | 8-K | Current Report |
Mar 5, 2025 | 8-K | Current Report |
Feb 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Feb 28, 2025 | DEF 14A | Other definitive proxy statements |
Feb 18, 2025 | PRE 14A | Other preliminary proxy statements |
Feb 7, 2025 | S-3 | Registration statement under Securities Act of 1933 |
Jan 28, 2025 | D | Notice of Exempt Offering of Securities |
Jan 15, 2025 | 8-K | Current Report |
Jan 7, 2025 | 8-K | Current Report |
Dec 5, 2024 | 8-K | Current Report |